Immunovant, Inc. (NASDAQ:IMVT) Investor Notice: Lawsuit Alleges Securities Laws Violations
An investor, who purchased shares of Immunovant, Inc. (NASDAQ:IMVT), filed a lawsuit over alleged violations of Federal Securities Laws by Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation.
View full press release